NasdaqGS:KMTSMedical Equipment
Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land
Kestra Medical Technologies (KMTS) shares are in focus after the company paired detailed fiscal 2026 results with fresh 2027 revenue guidance and a new multi tranche term loan facility that reshapes its funding profile.
See our latest analysis for Kestra Medical Technologies.
Kestra Medical Technologies’ latest earnings, 2027 revenue guidance and new term loan arrived after a choppy stretch, with a 1-day share price return of 1.8% and a 7-day share price return that declined 8.2%. However, a...